Aptevo Therapeutics Inc.(APVO US)
$1.61+0.000.00%Ext:$1.35-0.2616.36%(Market Closed · 23:47:19 UTC)
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY201312/31/2013 | FY201412/31/2014 | FY201512/31/2015 | FY201612/31/2016 | FY201712/31/2017 | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -17.4 | -24.1 | -26.0 | -26.3 | ||||||||||||
| Depreciation & Amortization | 0.6 | 0.4 | 0.2 | 0.2 | ||||||||||||
| Stock Based Compensation | 2.2 | 1.1 | 0.1 | -0.0 | ||||||||||||
| Change in Working Capital | 2.9 | -1.1 | -1.1 | -2.3 | ||||||||||||
| Other Non-Cash Items | 0.0 | - | 1.1 | 2.9 | ||||||||||||
| Net Cash from Operating Activities | -11.7 | -23.8 | -25.6 | -27.0 | ||||||||||||
| -Investments in Property, Plant & Equipment | - | - | - | - | ||||||||||||
| -Acquisitions Net | - | - | - | - | ||||||||||||
| -Purchases of Investments | - | - | - | - | ||||||||||||
| Sales/Maturities of Investments | - | - | - | - | ||||||||||||
| Other Investing Activities | - | - | - | - | ||||||||||||
| Net Cash from Investing Activities | - | - | - | - | ||||||||||||
| Net Debt Issuance | -3.5 | - | - | - | ||||||||||||
| Net Stock Issuance | 6.4 | 10.0 | 38.5 | 38.8 | ||||||||||||
| -Net Dividends Paid | - | - | - | - | ||||||||||||
| Other Financing Activities | 3.0 | 5.6 | - | 0.6 | ||||||||||||
| Net Cash from Financing Activities | 6.0 | 15.6 | 38.5 | 39.4 | ||||||||||||
| Effect of Forex Changes | - | - | - | - | ||||||||||||
| Net Change in Cash | -5.7 | -8.2 | 12.9 | 12.4 | ||||||||||||
| Cash at End of Period | 16.9 | 8.7 | 21.6 | 66.6 | ||||||||||||
| Operating Cash Flow | -11.7 | -23.8 | -25.6 | -27.0 | ||||||||||||
| -Capital Expenditure | - | - | - | - | ||||||||||||
| Free Cash Flow | -11.7 | -23.8 | -25.6 | -27.0 | ||||||||||||
